![Richard Glaze](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Glaze
Technik-/Wissenschafts-/F&E-Leiter bei TARO PHARMACEUTICAL INDUSTRIES LTD.
Aktive Positionen von Richard Glaze
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TARO PHARMACEUTICAL INDUSTRIES LTD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Richard Glaze
Ehemalige bekannte Positionen von Richard Glaze
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IKARIA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Richard Glaze
Princeton University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 4 |
Israel | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Taro Pharmaceutical Industries Ltd.
![]() Taro Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel. | Health Technology |
Ikaria, Inc.
![]() Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Börse
- Insiders
- Richard Glaze
- Erfahrung